Amiel Gross

Amiel Gross currently serves as Head of Legal at the Center for Breakthrough Medicines in Philadelphia, focusing on building and managing their legal functions. He is responsible for ensuring the business strategies and policies are aligned with all risks taken into consideration. Counselling executives and senior management, negotiating complex commercial transactions, facilitating strategic alliances, supporting a range of legal issues arising during highly-regulated biotechnology business operations - these topics highlight his work as an attorney who specialises in cell & gene therapy manufacturing.

This professional oversight responsibility and hands-on experience across an array of subjects. These subjects include licensing deals, master services agreements, procurement contracts, intellectual property, corporate affairs, sponsored R&D collaborations, FDA regulatory and compliance, litigation, labour and employment, cyber-security and privacy.

Amiel Gross studied International Law at the Queen Mary University of London. He holds a Bachelor of Arts Degree from Southwestern University and a Doctor of Law Degree from The University of Texas School of Law.

His skills include general corporate counsel, life science industry, biotechnology, industry knowledge, pharmaceutical law, bio pharmaceuticals, corporate law, licensing, regulatory compliance. He is also highly experienced at business transactions, commercial contracts, CDMO, CGT, cell and gene therapy.

  Philadelphia, PA, USA      

Work Experience

Head of Legal  •  Center for Breakthrough Medicines

June 2020 - Present

Amiel Gross serves as Head of Legal at the Center for Breakthrough Medicines at Philadelphia since 2020. He focuses on building and managing the legal function of a rapidly growing biotechnology company in cell and gene therapy manufacturing.

General Counsel  •  Discovery Labs

January 2020 - May 2020

Managed internal legal matters for Discovery Labs, a life science real estate holding company, in connection with the spinoff of its core operating business, Center for Breakthrough Medicines, a biotech startup focused on outsourced end-to-end manufacturing of Cell & Gene Therapy drug products.

Senior Associate  •  Dentons

August 2009 - October 2014

Senior Associate at Dentons, a global law firm driven to provide you with the competitive edge in an increasingly complex and interconnected marketplace.

Associate  •  Orrick, Herrington & Sutcliffe LLP

January 2001 - November 2006

Associate at Orrick, Herrington & Sutcliffe LLP, a global law firm focused on serving the technology & innovation, energy & infrastructure and finance sectors.


2004 - 2006

The University of Texas School of Law

Doctor of Law

2002 - 2005

Southwestern University School of Law


1999 - 2002

Queen Mary University of London

International Law


  • general corporate counsel
  • Life Science Industry
  • Biotechnology
  • Industry Knowledge
  • Pharmaceutical Law
  • biopharmaceuticals
  • Corporate Law
  • Licensing
  • Regulatory Compliance


  • English — Native or Bilingual